Mangano Carlo, Scarano Antonio, Perrotti Vittoria, Iezzi Giovanna, Piattelli Adriano
University of Chieti-Pescara, Italy.
Int J Oral Maxillofac Implants. 2007 Nov-Dec;22(6):980-6.
The aim of this study was to determine the clinical and histologic results of a porous synthetic hydroxyapatite (HA) compared with bovine-derived HA used in maxillary sinus augmentation.
A total of 100 titanium implants were placed in 40 patients. Patients in need of maxillary sinus augmentation were divided into 2 groups. Group 1 received bovine-derived HA (20 patients with 50 implants), while group 2 received a porous synthetic HA (20 patients with 50 implants). After a healing period of 6 months, second-stage surgery was carried out. In 50 cases (25 from group 1 and 25 from group 2), bone cores were harvested from grafted areas and processed for histologic examination.
Four implants that failed to osseointegrate were removed at the second-stage surgery (2 from a patient from group 1, and 2 from a patient from group 2). All patients were followed for at least 1 year after loading. Histologically, most of the HA particles from both groups were surrounded by newly formed bone. No statistically significant differences were found with respect to percentage of newly formed bone between the 2 groups (P = .031); however, the groups did differ significantly with respect to the percentage of residual graft material observed (P = .001).
This study demonstrates that both bovine-derived and porous synthetic HA can be used successfully as graft materials for maxillary sinus augmentation. The clinical performance of the 2 materials was similar. (Clinical Trial)
本研究旨在确定在上颌窦提升术中使用的多孔合成羟基磷灰石(HA)与牛源性HA相比的临床和组织学结果。
共40例患者植入100枚钛种植体。需要上颌窦提升的患者分为2组。第1组接受牛源性HA(20例患者,50枚种植体),而第2组接受多孔合成HA(20例患者,50枚种植体)。经过6个月的愈合期后,进行二期手术。在50例病例中(第1组25例,第2组25例),从移植区域获取骨芯并进行组织学检查。
在二期手术中取出4枚未实现骨整合的种植体(第1组1例患者的2枚,第2组1例患者的2枚)。所有患者在加载后至少随访1年。组织学上,两组的大多数HA颗粒都被新形成的骨包围。两组之间新形成骨的百分比无统计学显著差异(P = 0.031);然而,两组在观察到的残余移植材料百分比方面存在显著差异(P = 0.001)。
本研究表明,牛源性HA和多孔合成HA均可成功用作上颌窦提升的移植材料。两种材料的临床性能相似。(临床试验)